ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling

Background Cardiac hypertrophy has been recognized as an important independent risk factor for the development of heart failure and increases the risk of cardiac morbidity and mortality. A disintegrin and metalloprotease 23 (ADAM23), a member of ADAM family, is involved in cancer and neuronal differ...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Mei Xiang, Hongbo Luo, Jia Wu, Lingyun Ren, Xiangchao Ding, Chuangyan Wu, Jiuling Chen, Shanshan Chen, Hao Zhang, Lu Yu, Yanqiang Zou, Heng Xu, Ping Ye, Manhua Chen, Jiahong Xia
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2018-09-01
Schriftenreihe:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Schlagworte:	a disintegrin and metalloprotease23 Akt cardiac hypertrophy focal adhesion kinase
Online-Zugang:	https://www.ahajournals.org/doi/10.1161/JAHA.118.008604
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!